DUBLIN, Jan. 29, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter 2017 financialresults on February 27, 2018 and members of its senior management team will host a conference call and webcast before the U.S. financial markets open at 7:30 a.m. ET.
The dial-in number
A replay of the call will be available from February 27, 2018 at 10:30 a.m. ET until 10:30 a.m. ET on March 2, 2018 by dialing U.S./Canada (855) 859-2056, International (404) 537-3406, and entering the passcode 4978556.
A simultaneous webcast of the call can be accessed by visiting http://investor.endo.com/events-and-presentations. In addition, a replay of the webcast will be available on the Company website for one year following the event.
About Endo International plc
Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.
View original content:http://www.prnewswire.com/news-releases/endo-to-announce-fourth-quarter-2017-financial-results-300589301.html
SOURCE Endo International plc
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All